ALPHA — Pharnext SCA Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Pharnext SCA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -21.3 | -23.3 | -21.6 | -30.6 | -38.4 |
| Depreciation | |||||
| Non-Cash Items | 2.72 | 2.74 | 2.93 | 7.13 | 11.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.53 | -1.52 | 1.8 | -0.905 | 1.43 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -15.9 | -21.6 | -16.1 | -23.7 | -25.3 |
| Capital Expenditures | -0.404 | -0.072 | -0.032 | -0.077 | -0.035 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.002 | 0.265 | -0.03 | 0.103 | 0.469 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.402 | 0.194 | -0.061 | 0.026 | 0.434 |
| Financing Cash Flow Items | -1.83 | -1.41 | -1.62 | -1.09 | -1.99 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 26.6 | 14.9 | 11 | 20.6 | 17.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.3 | -6.51 | -5.17 | -3.11 | -7.37 |